In Search of a Better Cancer Treatment
Bret Ulery, an assistant professor in the Department of Biomedical, Biological and Chemical Engineering, recently received $298, 013 (per year for two years) from the National Institutes of Health (NIH) to explore “aptamer-modified POSH inhibitor micelles as a novel leukemia treatment modality;” in other words, find safer, more efficient treatment systems for ALL.